Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines

• Fabricio de Carvalho ,

  * E-mail: fcarvalho@unifesp.br

  Affiliation Disciplina de Hematologia e Hemoterapia, Universidade Federal de São Paulo, São Paulo, Brazil

  ⨯
• Erico T. Costa,

  Affiliation Laboratory of Molecular Biology and Genomics, Ludwig Institute for Cancer Research, São Paulo, Brazil

  ⨯
• Anamaria A. Camargo,

  Affiliation Laboratory of Molecular Biology and Genomics, Ludwig Institute for Cancer Research, São Paulo, Brazil

  ⨯
• Juliana C. Gregorio,

  Affiliation Recepta Biopharma, Ludwig Institute for Cancer Research, São Paulo, Brazil

  ⨯
• Cibele Masotti,

  Affiliation Laboratory of Molecular Biology and Genomics, Ludwig Institute for Cancer Research, São Paulo, Brazil

  ⨯
• Valeria C.C. Andrade,

  Affiliation Disciplina de Hematologia e Hemoterapia, Universidade Federal de São Paulo, São Paulo, Brazil

  ⨯
• Bryan E. Strauss,

  Affiliation Setor de Vetores Virais, Faculdade de Medicina, Laboratório de Genética e Cardiologia Molecular, InCor, São Paulo, Brazil

  ⨯
• Otavia L. Caballero,

  Affiliation Ludwig Collaborative Group, Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Djordje Atanackovic,

  Affiliation Department of Medicine II, Oncology/Hematology/Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  ⨯
• Gisele W.B. Colleoni

  Affiliation Disciplina de Hematologia e Hemoterapia, Universidade Federal de São Paulo, São Paulo, Brazil

  ⨯